Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

CNTA holding history

Centessa Pharmaceuticals plc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CNTA overviewAll 13F holders of CNTAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q2 2021
Holdings of CNTA by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−598,197−100.0%Sold outHolders
Q1 2026598,197$23.8M<0.1%+78,235+15.0%AddedHolders
Q4 2025519,962$13.0M<0.1%+382,761+279.0%AddedHolders
Q3 2025137,201$3.33M<0.1%+137,201NewHolders
Q2 20250$00.0%−706,331−100.0%Sold outHolders
Q1 2025706,331$10.2M<0.1%+81,015+13.0%AddedHolders
Q4 2024625,316$10.5M<0.1%+37,798+6.4%AddedHolders
Q3 2024587,518$9.39M<0.1%+549,242+1,435.0%AddedHolders
Q2 202438,276$345.6K<0.1%−8,692−18.5%ReducedHolders
Q1 202446,968$530.7K<0.1%−53,836−53.4%ReducedHolders
Q4 2023100,804$802.4K<0.1%+97,785+3,239.0%AddedHolders
Q3 20233,019$19.5K<0.1%−1,086−26.5%ReducedHolders
Q2 20234,105$25.4K<0.1%+4,105NewHolders
Q1 20230$00.0%−72,307−100.0%Sold outHolders
Q4 202272,307$224.2K<0.1%−153,061−67.9%ReducedHolders
Q3 2022225,368$906.0K<0.1%−65,215−22.4%ReducedHolders
Q2 2022290,583$1.42M<0.1%−13,843−4.5%ReducedHolders
Q1 2022304,426$2.73M<0.1%−35,639−10.5%ReducedHolders
Q4 2021340,065$3.83M<0.1%−9,483−2.7%ReducedHolders
Q3 2021349,548$5.84M<0.1%−106,685−23.4%ReducedHolders
Q2 2021456,233$10.1M<0.1%+456,233NewHolders